Literature DB >> 16616478

Stromal niches, plasma cell differentiation and survival.

Katrin Moser1, Koji Tokoyoda, Andreas Radbruch, Ian MacLennan, Rudolf A Manz.   

Abstract

Contacts made with other cells and stroma have a major impact on proliferation, differentiation, survival, migration and immunoglobulin class switching of plasma cell precursors as well as on the lifespan of the antibody-secreting cells. Induction of tissue-specific chemokine receptors and adhesion molecules directs migratory plasma cell precursors to tissues close to those in which the original immune stimulation occurred. This mechanism focuses the production of specific antibodies within a particular type of tissue, thus providing a means for the most efficient protection against tissue-specific pathogens. Relocation does not apply to long-lived plasma cells responsible for sustained titers of high-affinity systemic antibody. These are formed in germinal centers and migrate to specific niches in the bone marrow that support their further differentiation and long-term survival.

Mesh:

Year:  2006        PMID: 16616478     DOI: 10.1016/j.coi.2006.03.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  56 in total

1.  Differential expression of FCRLA in naïve and activated mouse B cells.

Authors:  Evdokiya S Reshetnikova; Ludmila V Mechetina; Olga Y Volkova; Sergey V Guselnikov; Nikolai A Chikaev; Dorottya Kövesdi; Boris Alabyev; Gabriella Sármay; Peter D Burrows; Alexander M Najakshin; Alexander V Taranin
Journal:  Cell Immunol       Date:  2011-10-22       Impact factor: 4.868

Review 2.  Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.

Authors:  Falk Hiepe; Thomas Dörner; Anja E Hauser; Bimba F Hoyer; Henrik Mei; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

3.  Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.

Authors:  Daniela A Bermejo; María C Amezcua Vesely; Mahmood Khan; Eva V Acosta Rodríguez; Carolina L Montes; Maria C Merino; Kai Michael Toellner; Elodie Mohr; Dale Taylor; Adam F Cunningham; Adriana Gruppi
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

Review 4.  3D and 4D imaging of immune cells in vitro and in vivo.

Authors:  Cindy Nitschke; Alexandre Garin; Marie Kosco-Vilbois; Matthias Gunzer
Journal:  Histochem Cell Biol       Date:  2008-10-15       Impact factor: 4.304

5.  ZBTB32 Restricts the Duration of Memory B Cell Recall Responses.

Authors:  Arijita Jash; Yinan Wang; Florian J Weisel; Christopher D Scharer; Jeremy M Boss; Mark J Shlomchik; Deepta Bhattacharya
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

Review 6.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

7.  Soluble CD38 significantly prolongs the lifespan of memory B-cell responses.

Authors:  Xue Q Liu; Derek N J Hart; Gordon G MacPherson; Michael F Good; Michelle N Wykes
Journal:  Immunology       Date:  2008-09       Impact factor: 7.397

8.  Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.

Authors:  Talibah U Metcalf; Victoria K Baxter; Voraphoj Nilaratanakul; Diane E Griffin
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 9.  The Tao of myeloma.

Authors:  Lawrence H Boise; Jonathan L Kaufman; Nizar J Bahlis; Sagar Lonial; Kelvin P Lee
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

10.  Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.

Authors:  Magda Nakou; Georgios Katsikas; Prodromos Sidiropoulos; George Bertsias; Eva Papadimitraki; Amalia Raptopoulou; Helen Koutala; Helen A Papadaki; Herakles Kritikos; Dimitrios T Boumpas
Journal:  Arthritis Res Ther       Date:  2009-08-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.